Deutsch English Français

Contact

EP3110806

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP3110806

EP3110806 - PHOSPHONATE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 19.10.2018 Database last updated on 24.04.2024
Former	Request for examination was made Status updated on 02.12.2016
Most recent event Tooltip	19.10.2018	Application deemed to be withdrawn	published on 21.11.2018 [2018/47]
Applicant(s)	For all designated states Achillion Pharmaceuticals, Inc. 300 George Street New Haven, CT 06511 / US
	[2017/01]
Inventor(s)	01 / WILES, Jason, Allan 116 Blinnshed Road Madison, CT 06443 / US
	02 / HASHIMOTO, Akihiro 47 Laurel Street Branford, CT 06405 / US
	03 / GADHACHANDA, Venkat, Rao 39 Ives Street Unit 104 Hamden, CT 06518 / US
	04 / PAIS, Godwin 370 West Todd Street Hamden, CT 06518 / US
	05 / WANG, Qiuping 79 Carriage Drive Bethany, CT 06524 / US
	06 / CHEN, Dawei 1117 Durham Road Guilford, CT 06437 / US
	07 / WANG, Xiangzhu 147 Foxbridge Village Road Branford, CT 06405 / US
	08 / AGARWAL, Atul 75 Nicholas Court Hamden, CT 06518 / US
	09 / DESHPANDE, Milind 44 Field Brook Road Madison, CT 06443 / US
	10 / PHADKE, Avinash, S. 51 Gilbert Lane Branford, CT 06405 / US
	[2017/01]
Representative(s)	Bassil, Nicholas Charles, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB
	[N/P]
Former [2017/01]	Bassil, Nicholas Charles, et al Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ / GB
Application number, filing date	15755701.8	25.02.2015
	[2017/01]
	WO2015US17600
Priority number, date	US201461944189P	25.02.2014 Original published format: US 201461944189 P
	US201462022916P	10.07.2014 Original published format: US 201462022916 P
	US201462046783P	05.09.2014 Original published format: US 201462046783 P
	[2017/01]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2015130845
	Date:	03.09.2015
	Language:	EN
	[2015/35]
	Type:	A1 Application with search report
	No.:	EP3110806
	Date:	04.01.2017
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 03.09.2015 takes the place of the publication of the European patent application.
	[2017/01]
Search report(s)	International search report - published on:	US	03.09.2015
	(Supplementary) European search report - dispatched on:	EP	20.10.2017
Classification	IPC:	C07F9/6558, A61P37/00, A61K31/416, A61K31/401	[2017/47]
	CPC:	A61K31/404 (EP,EA,IL,RU,US); C07F9/5728 (EA,IL,US); C07D403/14 (EP,EA,IL,KR,RU,US); A61K31/40 (EA); A61K31/401 (EA); A61K31/4045 (EP,EA,IL,US); (+) A61K31/407 (EP,EA,IL,US); A61K31/4155 (EA,RU); A61K31/416 (EA,KR); A61K31/4162 (EP,EA,IL,RU,US); A61K31/4178 (EP,EA,IL,US); A61K31/4184 (EP,EA,IL,US); A61K31/4188 (EP,EA,IL,US); A61K31/4192 (EP,EA,IL,US); A61K31/437 (EP,EA,IL,US); A61K31/4439 (EP,EA,IL,US); A61K31/444 (EP,EA,IL,US); A61K31/4709 (EP,EA,IL,US); A61K31/496 (EP,EA,IL,US); A61K31/501 (EP,EA,IL,KR,US); A61K31/506 (EP,EA,IL,KR,US); A61K31/519 (EP,EA,IL,KR,US); A61K31/536 (KR); A61K31/5377 (KR); A61K31/541 (EA,RU); A61K31/549 (EP,EA,IL,US); A61K31/55 (EP,EA,IL,US); A61K31/675 (EP,EA,IL,US); A61K31/683 (EP,EA,IL,US); A61K9/0014 (EA,IL,US); A61K9/0019 (EA,IL,US); A61K9/0048 (EA,IL,US); A61K9/0053 (EA,IL,US); A61P11/00 (EP,EA,KR,RU); A61P13/00 (EP,EA,KR); A61P13/02 (EP,EA,KR); A61P13/12 (EP,EA,RU); A61P19/02 (EP,EA,KR,RU); A61P25/00 (EP,EA,KR); A61P27/00 (EA,RU); A61P27/02 (EP,EA); A61P29/00 (EP,EA,KR); A61P37/00 (EP,EA); A61P43/00 (EP,EA); A61P7/00 (EP,EA,KR); A61P7/06 (EP,EA,RU); A61P9/00 (EP,EA,KR,RU); A61P9/10 (EP,EA); C07B59/002 (EA,IL,US); C07D209/12 (EA,IL,US); C07D209/14 (EA,IL,US); C07D209/30 (EA,IL,US); C07D209/40 (EA,IL,US); C07D209/42 (EA,IL,US); C07D209/44 (EA,IL,US); C07D209/88 (EA,IL,US); C07D401/14 (EP,EA,IL,KR,RU,US); C07D403/06 (EA,IL,US); C07D403/08 (EA,IL,US); C07D403/12 (EA,IL,RU,US); C07D405/12 (EA,IL,US); C07D405/14 (EA,IL,KR,US); C07D413/06 (EA,IL,US); C07D413/14 (EA,IL,KR,US); C07D417/04 (EA); C07D417/06 (EA,IL,US); C07D417/12 (EA,IL,US); C07D417/14 (EA,IL,KR,US); C07D471/04 (EA,IL,KR,RU,US); C07D471/08 (EA,IL,US); C07D487/04 (EA,IL,KR,US); C07D487/14 (EA,IL,US); C07D491/113 (EA,IL,US); C07D495/04 (EA,IL,RU,US); C07D513/04 (EA,IL,KR,RU,US); C07F5/025 (EP,EA,IL,US); C07F5/027 (EA,IL,US); C07F7/0812 (EA,IL,US); C07F9/65583 (EP,EA,IL,US); C07F9/6561 (EP,EA,IL,US); C07F9/65616 (EA,IL,US); C07B2200/05 (EA,IL,US) (-)
	Former IPC [2017/01]	C07D401/14, C07D403/14, C07D471/04
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/01]
Title	German:	PHOSPHONATVERBINDUNGEN ZUR BEHANDLUNG VON KOMPLEMENTVERMITTELTEN ERKRANKUNGEN	[2017/01]
	English:	PHOSPHONATE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS	[2017/01]
	French:	PHOSPHONATES POUR LE TRAITEMENT DE TROUBLES FAISANT INTERVENIR LE COMPLÉMENT	[2017/01]
Entry into regional phase	23.09.2016	National basic fee paid
	23.09.2016	Search fee paid
	23.09.2016	Designation fee(s) paid
	23.09.2016	Examination fee paid
Examination procedure	23.09.2016	Examination requested [2017/01]
	23.09.2016	Date on which the examining division has become responsible
	05.05.2017	Amendment by applicant (claims and/or description)
	19.05.2018	Application deemed to be withdrawn, date of legal effect [2018/47]
	26.06.2018	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2018/47]
Fees paid	Renewal fee
	10.02.2017	Renewal fee patent year 03
	Penalty fee
	Additional fee for renewal fee
	28.02.2018	04 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]WO2014009833 (NOVARTIS AG [CH], et al) [A] 1-16* claim 1 *
	International search	[A]WO2012093101 (NOVARTIS AG [CH], et al) [A] 14-15, 18, 19/14-15, 19/18, 20/14-15, 20/18, 21/18, 23/18, 24/18, 25/18, 26/19/14-15, 26/19/18, 27/19/14-15, 27/19/18, 28/19/14-15, 28/19/18, 29/19/14-15, 29/19/18 * ; page 3, third paragraph; page 421, see Example 597; page 462, see Example 728 *;
		[XA]WO2014002057 (NOVARTIS AG [CH], et al) [X] 1-13, 16-17, 19/1, 19/13, ,19/16-17, 20/1, 20/13, 20/16-17, 26/19/1, 26/19/13, 26/19/16-17, 27/19/1, 27/19/13, 27/19/16-17, 28/19/1, 28/19/13, 28/19/16-17, 29/19/1, 29/19/13, 29/19/16-17 * ; page 4, second paragraph, fourth paragraph; page 5, second paragraph, see Formula I; page 23, second paragraph; page 32, seventh paragraph; page 33, first-fourth paragraphs; page 34, first paragraph; page 35, first paragraph; page 37, third paragraph; page 38, seventh paragraph; page 77, see Examp * [A] 14-15, 18, 19/14-15, 19/18, 20/14-15, 20/18, 21/18, 23/18, 24/18, 25/18, 26/19/14-15, 26/19/18, 27/19/14-15, 27/19/18, 28/19/14-15,- 28/19/18, 29/19/14-15, 29/19/18;
		[A] - COLE, LB et al., "Structure of 3,4-Dichloroisocoumarin-Inhibited Factor D", Acta Cryst. D54, (19980000), pages 711 - 717, XP055220052 [A] 14-15, 18, 19/14-15, 19/18, 20/14-15, 20/18, 21/18, 23/18, 24/18, 25/18, 26/19/14-15, 26/19/18, 27/19/14-15, 27/19/18, 28/19/14-15, 28/19/18, 29/19/14-15, 29/19/18 * ; entire document *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p